Askar Kleefeldt

Askar is Co-Founder of SynX Therapeutics, a London-based biotech start-up developing a rapid drug discovery platform for peptide therapeutics. His work spans synthetic biology technology development across drug discovery, medical countermeasures, and synthetic genomics. During his doctoral research at the MRC Laboratory of Molecular Biology, Cambridge, Askar developed methods for megabase-scale DNA assembly and whole-genome synthesis of E. coli.

​

Askar has worked on policy questions related to biosecurity and the bioeconomy and contributes to EU medical countermeasure policy via DG HERA's Joint Industrial Cooperation Forum.